0
Research Papers

Design Optimization of an Implantable Device Concept for Passive Ocular Drug Delivery

[+] Author and Article Information
Jonathan Marsh

Department of Mechanical
and Nuclear Engineering,
Virginia Commonwealth University,
Richmond, VA 23284

Ramana M. Pidaparti

College of Engineering,
University of Georgia,
Athens, GA 30602

1Present address: Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, VA 23284.

Manuscript received October 18, 2013; final manuscript received December 17, 2013; published online March 7, 2014. Assoc. Editor: Rupak K. Banerjee.

J. Med. Devices 8(2), 021005 (Mar 07, 2014) (6 pages) Paper No: MED-13-1260; doi: 10.1115/1.4026451 History: Received October 18, 2013; Revised December 17, 2013

This paper presents an implantable device concept with applications for treating ocular diseases such as glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, and retinitis pigmentosa. The design of a biodegradable drug delivery device concept consisting of a polydimethylsiloxane (PDMS) shell with a fluid reservoir and micro/nanofluidic tubes that allow the drug to be stored and delivered at a specified rate is discussed. Computational fluid dynamics simulations were conducted through various tube configurations in order to obtain the drug diffusion characteristics. The results from the simulation studies revealed information related to drug transport under varying design parameters. The design simulations were conducted with a desired rate. Based on results from several simulations, an optimization study was conducted to achieve the required dosage for about 2 years. The results obtained from the optimization study shows that the device concept can be extended for different drugs to treat ocular diseases.

FIGURES IN THIS ARTICLE
<>
Copyright © 2014 by ASME
Your Session has timed out. Please sign back in to continue.

References

Gaudana, R., Jwala, J., Boddu, S. H. S., and Mitra, A. K., 2009, “Recent Perspectives Ocular Drug Delivery,” Pharm. Res., 26(5), pp. 1197–1216. [CrossRef]
Geroski, D. H., and Edelhauser, H. F., 2000, “Drug Delivery for Posterior Segment Eye Disease,” Invest. Ophthalmol. Visual Sci., 41(5), pp. 961–964.
Lee, J. H., Pidaparti, R. M., Atkinson, G. M., and Moorthy, R. S., 2012, “Design of an Implantable Device for Ocular Drug Delivery,” J. Drug Delivery, 2012, p. 527516. [CrossRef]
Lo, R., Li, P.-Y., Saati, S., Agarwal, R. N., Humayun, M. S., and Meng, E., 2009, “A Passive MEMS Drug Delivery Pump for Treatment of Ocular Diseases,” Biomed. Microdevices, 11(5), pp. 959–970. [CrossRef]
Staples, M., Daniel, K., Cima, M. J., and Langer, R., 2006, “Application of Micro- and Nano-Electromechanical Devices to Drug Delivery,” Pharm. Res., 23(5), pp. 847–863. [CrossRef]
Molokhia, S. A., Sant, H., Simonis, J., Bishop, C. J., Burr, R. M., Gale, B. K., and Ambati, B. K., 2010, “The Capsule Drug Device: Novel Approach for Drug Delivery to the Eye,” Vision Res., 50(7), pp. 680–685. [CrossRef]
Khanafer, K., Duprey, A., Schlicht, M., and Berguer, R., 2009, “Effects of Strain Rate, Mixing Ratio, and StressStrain Definition on the Mechanical Behavior of the Polydimethylsiloxane (PDMS) Material as Related to Its Biological Applications,” Biomed. Microdevices, 11(2), pp. 503–508. [CrossRef]
Swanson, S. D., 2006, “Selective MRI and MRS of PEGylated compounds,” Proceedings of the 14th Scientific Meeting International Society for Magnetic Resonance in Medicine, Seattle, WA, May 6–12.
Li, T., Kildsig, D. O., and Park, K., 1997, “Computer Simulation of Molecular Diffusion in Amorphous Polymers,” J. Controlled Release, 48(1), pp. 57–66. [CrossRef]
Jaffe, G. J., Yang, C. H., Guo, H., Denny, J. P., Lima, C., and Ashton, P., 2000, “Safety and Pharmacokinetics of an Intraocular Fluocinolone Acetonide Sustained Delivery Device,” Invest. Ophthalmol. Visual Sci., 41(11), pp. 3569–3575.
Thrimawithana, T. R., Young, S., Bunt, C. R., Green, C. R., and Alany, R. G., 2011, “Drug Delivery to the Posterior Segment of the Eye: Challenges and Opportunities,” Drug Delivery Lett., 1(1), pp. 40–44.
Arora, J. S., 2012, Introduction to Optimum Design, 3rd ed., Elsevier Academic, New York.

Figures

Grahic Jump Location
Fig. 1

Proposed device design concept for passive ocular drug delivery

Grahic Jump Location
Fig. 2

An overview of the attachment of the implanted drug delivery device to the eye

Grahic Jump Location
Fig. 3

Initial conditions for design simulations

Grahic Jump Location
Fig. 4

Simulation results of drug concentration through a single microchannel at various times

Grahic Jump Location
Fig. 5

Simulations of drug diffusion rate with time for R = 0.08 mm and L = 0.1–0.3 mm

Grahic Jump Location
Fig. 6

Simulations of diffusion rate for different L with R = 0.08 mm

Grahic Jump Location
Fig. 7

Sensitivity of diffusion rate for various R with L = 0.43 mm

Grahic Jump Location
Fig. 8

Sensitivity of diffusion rate for various R = 0.08 mm with L = 0.37–0.45 mm

Grahic Jump Location
Fig. 9

Diffusion rate for the optimized device design

Grahic Jump Location
Fig. 10

Concentration change over time for the optimized device design

Tables

Errata

Discussions

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging and repositioning the boxes below.

Related Journal Articles
Related eBook Content
Topic Collections

Sorry! You do not have access to this content. For assistance or to subscribe, please contact us:

  • TELEPHONE: 1-800-843-2763 (Toll-free in the USA)
  • EMAIL: asmedigitalcollection@asme.org
Sign In